Dr. Mortazavi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1700 N Rose Ave Suite 320
Oxnard, CA 93030Phone+1 805-485-8709Fax+1 805-485-5521
Education & Training
- University of Illinois College of Medicine at ChicagoFellowship, Hematology and Medical Oncology, 2003 - 2006
- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2000 - 2002
- Mount Sinai Medical Center of FloridaInternship, Internal Medicine, 1999 - 2000
- Tehran University of Medical Sciences School of MedicineClass of 1996
Certifications & Licensure
- CA State Medical License 2006 - 2025
- IL State Medical License 2002 - 2008
- NY State Medical License 2002 - 2004
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 24 citationsSignificance of KRAS/PAK1/Crk pathway in non-small cell lung cancer oncogenesisFariborz Mortazavi, Jie Lu, Ryan Phan, Michael T. Lewis, Kenny Trinidad
BMC Cancer. 2015-05-09 - 45 citationsProtein kinase C α enhances migration of breast cancer cells through FOXC2-mediated repression of p120-cateninThao Pham, Bethany E. Perez White, Huiping Zhao, Fariborz Mortazavi, Debra A. Tonetti
BMC Cancer. 2017-12-07 - 101 citationsCTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model sy...Polly D. Gregor, Jedd D. Wolchok, Cristina R. Ferrone, Heidi Buchinshky, José A. Guevara-Patiño
Vaccine. 2004-04-16
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: